Cane Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Cane Capital Partners's LLY Position: Q3 2026 in Review
Cane Capital Partners increased its Eli Lilly (LLY) stake by 12% in Q3 2026, buying an estimated $496K and bringing the position to 3,818 shares worth $4.42M. The position accounts for 1.64% of the portfolio, ranked #17.
Cane Capital Partners first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Cane Capital Partners held 3,818 shares of Eli Lilly worth $4.42M as of Q3 2026.
- Cane Capital Partners bought 420 Eli Lilly shares in Q3 2026, an estimated $496K.
- Eli Lilly made up 1.64% of Cane Capital Partners's portfolio in Q3 2026, its #17 holding.
- Cane Capital Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Cane Capital Partners's 13F filing for Q3 2026, filed 23 Oct 2026.